The Whole Price of Vancomycin: Toxicities, Troughs, and Time Meghan N. Jeffres Current Opinion Open access 01 June 2017 Pages: 1143 - 1154
A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs? Wendy L. St. PeterLori D. WaznyJoanna Q. Hudson Review Article 05 June 2017 Pages: 1155 - 1186
The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis Amirhossein SahebkarMaria-Corina Serbanfor the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group Systematic Review Open access 01 June 2017 Pages: 1187 - 1197
A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls Erin KeltyGary Hulse Original Research Article 23 May 2017 Pages: 1199 - 1210
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates Erin KeltyGary Hulse Original Research Article 23 May 2017 Pages: 1211 - 1219
Abatacept: A Review in Rheumatoid Arthritis Hannah A. BlairEmma D. Deeks Adis Drug Evaluation 12 June 2017 Pages: 1221 - 1233
Eftrenonacog Alfa: A Review in Haemophilia B Sheridan M. Hoy Adis Drug Evaluation 23 June 2017 Pages: 1235 - 1246
Cerliponase Alfa: First Global Approval Anthony Markham AdisInsight Report 06 June 2017 Pages: 1247 - 1249
Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects Shubhasree BanerjeeAnn BiehlDaniella M. Schwartz Erratum 12 June 2017 Pages: 1261 - 1261